VHI vs. CF, ROG, SLI, ESI, FF, IGX, ICL, PRM, REX, and OEC
Should you be buying Vitalhub stock or one of its competitors? The main competitors of Vitalhub include Canaccord Genuity Group (CF), Roxgold (ROG), Standard Lithium (SLI), Ensign Energy Services (ESI), First Mining Gold (FF), IntelGenx Technologies (IGX), Itasca Capital Ltd. (ICL.V) (ICL), Cott (PRM), Orex Minerals (REX), and Oracle Energy (OEC). These companies are all part of the "chemicals" industry.
Vitalhub vs. Its Competitors
Vitalhub (TSE:VHI) and Canaccord Genuity Group (TSE:CF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability.
Canaccord Genuity Group received 327 more outperform votes than Vitalhub when rated by MarketBeat users. However, 75.00% of users gave Vitalhub an outperform vote while only 53.27% of users gave Canaccord Genuity Group an outperform vote.
Vitalhub has higher earnings, but lower revenue than Canaccord Genuity Group. Canaccord Genuity Group is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.
Vitalhub has a net margin of 5.11% compared to Canaccord Genuity Group's net margin of -1.33%. Vitalhub's return on equity of 3.01% beat Canaccord Genuity Group's return on equity.
32.4% of Vitalhub shares are owned by institutional investors. Comparatively, 11.8% of Canaccord Genuity Group shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by insiders. Comparatively, 4.6% of Canaccord Genuity Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Vitalhub has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, Canaccord Genuity Group has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500.
Vitalhub presently has a consensus target price of C$13.08, suggesting a potential upside of 18.94%. Canaccord Genuity Group has a consensus target price of C$12.38, suggesting a potential upside of 31.51%. Given Canaccord Genuity Group's higher probable upside, analysts clearly believe Canaccord Genuity Group is more favorable than Vitalhub.
In the previous week, Canaccord Genuity Group had 3 more articles in the media than Vitalhub. MarketBeat recorded 16 mentions for Canaccord Genuity Group and 13 mentions for Vitalhub. Vitalhub's average media sentiment score of 0.71 beat Canaccord Genuity Group's score of 0.51 indicating that Vitalhub is being referred to more favorably in the media.
Summary
Vitalhub beats Canaccord Genuity Group on 13 of the 18 factors compared between the two stocks.
Get Vitalhub News Delivered to You Automatically
Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vitalhub Competitors List
Related Companies and Tools
This page (TSE:VHI) was last updated on 6/13/2025 by MarketBeat.com Staff
